Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Non Operating Income (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Non Operating Income for 7 consecutive years, with $11.3 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 18.29% to $11.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.6 million through Dec 2025, down 13.11% year-over-year, with the annual reading at $45.6 million for FY2025, 13.11% down from the prior year.
  • Non Operating Income hit $11.3 million in Q4 2025 for IDEAYA Biosciences, up from $10.8 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $15.1 million in Q3 2024 to a low of $104000.0 in Q2 2021.
  • Historically, Non Operating Income has averaged $6.2 million across 5 years, with a median of $5.4 million in 2023.
  • Biggest five-year swings in Non Operating Income: plummeted 73.79% in 2021 and later skyrocketed 1328.03% in 2022.
  • Year by year, Non Operating Income stood at $157000.0 in 2021, then surged by 1328.03% to $2.2 million in 2022, then surged by 255.13% to $8.0 million in 2023, then surged by 73.65% to $13.8 million in 2024, then decreased by 18.29% to $11.3 million in 2025.
  • Business Quant data shows Non Operating Income for IDYA at $11.3 million in Q4 2025, $10.8 million in Q3 2025, and $11.3 million in Q2 2025.